Delivery Order 75F40121D00032-75F40126F19003

This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $1,024,971 contract is for data resources and surveillance reports to support post-marketing monitoring of non-medical use of pharmaceuticals and illicit drug use. The contract has a six-month performance period with a completion date of September 29, 2026. This delivery order is part of a larger $10 million FDA indefinite...

The Food and Drug Administration (FDA) awarded a $1.05M firm-fixed-price delivery order to Integrated Behavioral Health, Inc. to conduct research understanding the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among populations being assessed for or entering substance use disorder treatment. The work will be performed in Silver Spring, Maryland, with an ultimate completion date of September 28, 2027. This delivery order was awarded without a...

The Food and Drug Administration issued a delivery order to Denver Health And Hospital Authority on September 30, 2021, with a ceiling value of $695,889 for data resources supporting post-marketing surveillance of nonmedical use of pharmaceuticals and illicit drug substances under Executive Order 14398. Ultimate completion is scheduled for December 29, 2026. Place of performance is Denver, CO. The order is priced on a firm fixed-price basis with no set-aside. Service Contract Inventory reporting...

<p>The Food and Drug Administration awarded a $173,975 definitive contract to Emory University for Executive Order 14398 compliance work on September 6, 2026, under firm fixed-price pricing with no set-aside.</p> <p>Place of performance is Silver Spring, Maryland. The contract runs through September 5, 2027. The source does not specify the originating solicitation scope or detailed deliverables beyond the EO 14398 reference.</p>

<p>The Food and Drug Administration issued a purchase order to Parenteral Drug Association, Inc. for $74,916.00 on September 14, 2026, to support the Parenteral Drug Association/Food and Drug Administration Joint Regulatory Conference 2026 under Executive Order 14398. Place of performance is Washington, DC. The order carries a firm fixed price structure with an ultimate completion date of September 16, 2026. No small business set-aside applies.</p>

The Food and Drug Administration issued a delivery order to the Massachusetts Department of Public Health on May 20, 2025, with a ceiling value of $864,696.30, under a parent Indefinite Delivery Contract for tobacco inspection and compliance services in Massachusetts with an ultimate completion date of May 29, 2026. The parent IDC, awarded to MDPH by FDA with a total ceiling of $9,053,849, supports ongoing tobacco inspection and compliance activities through September 2029. Under this delivery...

The Department of Health and Human Services Food and Drug Administration awarded a $145,636.17 firm fixed price delivery order to We Pharma, Inc. of Silver Spring, Maryland for pharmaceutical products to support domestic manufacturing. No set-aside provisions were applied to this contract. We Pharma will provide the FDA's Office of Pharmaceutical Quality with domestic pharmaceutical manufacturing supplies through September 30th, 2022 at their Silver Spring location. As the regulatory body...

The Food and Drug Administration issued a delivery order to Watch House International LLC on June 17, 2024, with a ceiling value of $23,843.80 under a Total Small Business set-aside for training in personal safety when performing duties related to the Federal Food, Drug, and Cosmetic Act and related regulations. Place of performance is Silver Spring, MD. The order is firm fixed price with an ultimate completion date of June 28, 2024. This modification updated the travel amount associated with...

The Food and Drug Administration issued a delivery order to Data Quality Science, LLC on September 23, 2025, with a ceiling value of $186,106.67, under a total small business set-aside. The order is issued under the FDA's Region 4 IDIQ for tobacco retailer compliance inspection services, a $35 million total small business set-aside indefinite delivery contract awarded September 24, 2021, with an ultimate completion date of September 29, 2026. Place of performance is Baltimore, MD. The delivery...

<p>The Food and Drug Administration issued a purchase order to Outfront Media Inc. for $324,000 on August 1, 2026 to execute an HR recruitment advertising campaign. Place of performance is Silver Spring, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of July 31, 2027. No small business set-aside applies.</p>